Specialty Pharmaceuticals Businesses for Sale and Investment

The company is a certified pharmaceutical formulations manufacturing company, specializing in tablets, capsules (soft and hard gelatin), liquid orals (syrups), and ointments. - Our primary business model is B2B, supplying to 50 stockists and 30 retailers. - The company holds multiple certifications and regulatory approvals, including WHO GMP (Good Manufacturing Practices), ISO 9001:2015 – Quality Management System, FSSAI (Food Safety and Standards Authority of India), CDSCO (Central Drugs Standard Control Organization), Ayush license, and State FDA approval. - Production capacity and utilization: 1) Tablets: Installed capacity – 1.03 crore units; current utilization – 30 to 80 lakh units. 2) Soft gelatin capsules: Installed capacity – 25 lakh units; utilization – 25 lakh units. 3) Hard gelatin capsules: Installed capacity – 15 lakh units; utilization – 9 lakh units. 4) Syrups (liquid orals): Installed capacity – 75,000 units; utilization – 13,000 units. 5) Ointments: Installed capacity – 5,000 tubes; utilization – 3,000 tubes. - Sales have significantly increased this year due to a strategic shift from generic drugs to ethical marketing and in-house specialty prescription formulations, resulting in higher profitability and stronger brand positioning. - The company is registered as a public limited entity and holds a valid GST license. - The company is registered in Indore, and we have our manufacturing unit in Dewas.

Our company, AUV Healthcare Pvt Ltd, is a leading distributor of medical equipment, including ultra-low-temperature freezers and laboratory equipment. We are expanding our reach through a franchise distribution model and anticipate an average revenue per outlet ranging from INR 50 lakh to INR 1 crore per annum, depending on location, market demand, and sales performance. We offer a comprehensive portfolio of medical equipment and laboratory instruments from leading manufacturers. Our team possesses extensive technical expertise and experience in the field, ensuring that franchisees receive the necessary knowledge and support. We provide excellent after-sales service, maintenance, and repair support to our customers while maintaining competitive pricing without compromising product quality or service standards. Our business model has been tested and refined over the years, minimizing the risk of failure. Our team will deliver comprehensive training and support to equip you with the technical knowledge needed for success. Franchisees will have access to our extensive product portfolio and benefit from competitive pricing, enabling them to offer attractive rates to customers. With this model, there is potential for a high return on investment, depending on sales performance and market demand. By franchising with us, you can establish a successful and profitable business in the medical equipment distribution industry. We also have GST, MSME registration, incorporation, and a PAN number. We do not need USFDA approval.

Our company, AUV Healthcare Pvt Ltd, is a leading distributor of medical equipment, including ultra-low-temperature freezers and laboratory equipment. We are expanding our reach through a franchise distribution model and anticipate an average revenue per outlet ranging from INR 50 lakh to INR 1 crore per annum, depending on location, market demand, and sales performance. We offer a comprehensive portfolio of medical equipment and laboratory instruments from leading manufacturers. Our team possesses extensive technical expertise and experience in the field, ensuring that franchisees receive the necessary knowledge and support. We provide excellent after-sales service, maintenance, and repair support to our customers while maintaining competitive pricing without compromising product quality or service standards. Our business model has been tested and refined over the years, minimizing the risk of failure. Our team will deliver comprehensive training and support to equip you with the technical knowledge needed for success. Franchisees will have access to our extensive product portfolio and benefit from competitive pricing, enabling them to offer attractive rates to customers. With this model, there is potential for a high return on investment, depending on sales performance and market demand. By franchising with us, you can establish a successful and profitable business in the medical equipment distribution industry. We also have GST, MSME registration, incorporation, and a PAN number. We do not need USFDA approval.

Established in Vizag JN Pharma City, this API manufacturer operates in a prime location known for its robust infrastructure in the pharmaceuticals industry, catering to domestic and international markets. - Specializes in high-demand active pharmaceutical ingredients (APIs) across various therapeutic categories including oncology, diabetes, cardiovascular, and anti-allergic drugs, appealing to top pharmaceutical formulators both in India and abroad. - Boasts a strong international presence with export relationships across Japan, UK, France, and Bangladesh, indicating its credibility and demand in diverse markets. - Serves a substantial client base of 40 to 50, highlighting a stable and expanding market reach with an emphasis on both domestic and export clientele. - The facility has an advanced production capacity of 98 kiloliters, with the potential to scale operations to 250 kiloliters, underscoring its readiness for increased demand and large-scale API manufacturing. - Holds ISO 9000 certification, underscoring its commitment to quality management systems and ensuring compliance with internationally recognized standards. - The business is incorporated and features USFDA approval for one of its products, reinforcing its competitive position and enabling access to the lucrative US pharmaceuticals market. - The operations have been halted due to non-payment of a working capital loan, and the bank has seized the assets due to NPA.

Specialty pharma marketing company with a focus on gynaecology and orthopaedics products. - Located in Hyderabad, Telangana, the company achieves monthly sales of approximately INR 12 to 15 lakh. - The product portfolio primarily consists of gynecologic and orthopaedic products, with gynecologic items being the top-selling category. - Serving a diverse clientele including multi-specialty hospitals, clinics, and pharmacies, ensuring wide market access. - The business is fully registered with GST and has a valid Certificate of Incorporation, enhancing credibility. - The sale includes all registered product brands and existing inventory, offering immediate operational capability for the buyer. - Currently not USFDA approved and all brands are registered but not trademarked, presenting opportunities for future brand development and market expansion. - A dedicated team of 13 employees is in place to facilitate a smooth transition for new ownership.

The business is a pharmaceutical manufacturer based out of Jassur, Himachal Pradesh. - Distributing products through a network of six distributors. - Company has established strategic partnerships and distribution channels, as evidenced by its recent deal with Fortis and its tie-up with Tata 1mg. - With a strong online presence, the business has listed its products on Amazon, showcasing its commitment to leveraging e-commerce platforms for sales and visibility. - The company has effectively outsourced its manufacturing operations, potentially offering flexibility and cost-efficiency in production. - The business benefits from the expertise of its promoter, who brings 24 years of experience in the industry and holds an MSc in medicine, specializing in the formulation of medicines. - The company holds multiple certifications, including FDA-approved products, WHO-GMP certification, UKAI certification, ISO 9001:2015, and MSME certification, demonstrating a commitment to quality and compliance with international standards.

We are working with five clients. We are a research-based product development partner to pharmaceutical companies. Promoter experience: Promoter is a pharmaceutical professional with 18+ years of work experience (Formulation scientist) turned to healthcare entrepreneur. In 3 years, business will reach USD 2 million revenue per year. We signed up new clients this year and have already achieved INR 1 Cr for this year. More clients are in the pipeline. We generate almost equal revenue from fee for service model and in-house asset sale model.

Ahmedabad based pharmaceutical research company focusing on the NDA, 505 (B) (2), and complex formulations. - We have 8 products in the pipeline for 505 (2) (2) US along with a ready contract R&D business of $1 million. - Business has no liability. - Company has 2 shareholders. - We have 4 active US clients who give regular business. - We have confirmed orders for the future which will be forwarded to the new buyer.

We are a pharma company established in Nepal and have a pharma wholesale unit. - The business has tie-ups with many wholesale and retail outlet. - Pharmaceutical industry in Nepal has been emerging as the best investment sector in the last few years. - We are planning to start our own manufacturing unit. The unit is not operational as of now. - The building and some machinery are ready. - We specialize in allopathic medicines. - Have more than 15 years of experience in this sector.

Updates on the business: The facility will have growing/extraction/distillation/packaging and R&D lab facilities in order to follow the entire stage of production from mother plants to crystallized forms of stand-alone cannabinoids. The intended R&D lab will be almost 200 sq. m. and will allow us to study lesser-known cannabinoids, and after the start of construction, we are going to sign the 'Partnership Joint Research' program with Athens University. Currently have signed a partnership agreement with a running pharmaceutical company on product supply + joint research program. Later on, we will focus on the distribution channels in each country of presence in order to be prepared to scale to the B2C market with potential own generic medicine and potentially edibles, but that will be decided by the market needs and legislation. We have received an installation license for such end products and as the project progresses we will add new products to the list: - Dried hemp flower > 0.2% THC in the form of teabag (tea bag) for oral consumption; - Hemp oil in drops for oral consumption > 0.2% THC; - Hemp oil for sublingual oral consumption (spray) > 0.2% THC; - Soft cannabis capsules for oral consumption > 0.2% THC; - Capsules with dried hemp blossom > 0.2% THC in powder form for oral consumption. At the moment we have: License and permits; Architectural and engineering plans; Purchase offers from equipment suppliers; All described production processes and laboratories; Long-term land lease for 30+ years with first an option of first to purchase it; Long-term lease and right of build on the neighboring land for the second stage of construction; The entire legal structure of the holding; Verification of processes and architectural solutions under EU GACP & EU GMP standards. By the end of last year have applied for the state subsidy of EUR 3.5mil and have the option to apply for the second state subsidy next year. Additionally, the project has a right for setting fixed corporate tax for the next 12 years. Overall the production facility is projected to grow 6.5+ tons of dried biomaterial (running at 70% capacity) on a single-tier growing table with the ability of scale and potential purchase of third-party biomaterial certified by GACP standards. The EU GMP Laboratory is projected to produce 2+ tons of fine oil with an option of scaling by putting a second processing line. Additionally, the project is built in mind with an option for a second-stage expansion through the building of an additional production site on the neighboring land.